Literature DB >> 15368333

Medullomyoblastoma: a radiographic and clinicopathologic analysis of six cases and review of the literature.

Kathleen J Helton1, Maryam Fouladi, Frederick A Boop, Arie Perry, James Dalton, Larry Kun, Christine Fuller.   

Abstract

BACKGROUND: Medullomyoblastoma (MMB) is a rare cerebellar embryonal neoplasm that occurs almost exclusively in children. It is biphasic by microscopy, containing myoblastic and primitive neuroectodermal components.
METHODS: The authors conducted a retrospective review of the radiographic and pathologic characteristics, treatment, and clinical outcomes of six children with MMB who were treated at St. Jude Children's Research Hospital (Memphis, TN) between 1984 and 2003. Fluorescence in situ hybridization (FISH) data were available for four children. A literature review also was conducted and focused on imaging and pathologic findings.
RESULTS: The median age at diagnosis was 4.5 years (range, 0.83-7.5 years). Radiographically, all tumors were cerebellar and exhibited variable enhancement, and 50% of tumors had necrotic foci. Three tumors contained discrete, magnetic resonance imaging (MRI) T2-weighted-hypointense/computed tomography (CT)-hyperdense enhancing regions and separate hyperintense/hypodense nonenhancing regions, which correlated microscopically with geographic islands of primitive neuroectodermal and rhabdomyoblastic cells. Large cell/anaplastic (five tumors), nodular/desmoplastic (two tumors), and classic (two tumors) medulloblastoma histologies were encountered either alone (five tumors) or in combination with each other (two tumors). All 4 tumors that were tested exhibited alterations in chromosome 17 or c-myc amplification. All patients underwent macroscopic total resection and subsequently received chemotherapy and craniospinal (five patients) or local conformal (one patient) radiotherapy. At a median follow-up of 92 months (range, 23-187 months), 3 patients remain alive with no evidence of disease, 2 patients have died of disease, and 1 patient has died of secondary acute lymphocytic leukemia.
CONCLUSIONS: The results of the current study demonstrated the frequent correlation of biphasic nodularity (as determined by MRI or CT) with discrete rhabdomyoblastic and primitive neuroectodermal islands (as revealed by microscopy) in MMB. These results also support the view that MMB and medulloblastoma may have common tumorigenic origins, given their similar histologic and molecular features. Copyright 2004 American Cancer Society.

Entities:  

Mesh:

Year:  2004        PMID: 15368333     DOI: 10.1002/cncr.20450

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Isochromosome 17q, MYC amplification and large cell/anaplastic phenotype in a case of medullomyoblastoma with extracranial metastases.

Authors:  Karen D Wright; Kendra von der Embse; Jamie Coleman; Zoltan Patay; David W Ellison; Amar Gajjar
Journal:  Pediatr Blood Cancer       Date:  2011-12-06       Impact factor: 3.167

2.  Neuro-oncology in a nutshell.

Authors:  Joachim M Baehring
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

3.  Large cell medulloblastoma with myogenic and melanotic differentiation: a case report with molecular analysis.

Authors:  Alexandros D Polydorides; Arie Perry; Mark A Edgar
Journal:  J Neurooncol       Date:  2008-06       Impact factor: 4.130

4.  Medulloblastoma with myogenic differentiation: a rare medulloblastoma variant in a young child.

Authors:  John Ross Crawford; Michael L Levy
Journal:  BMJ Case Rep       Date:  2015-08-21

5.  Medulloblastoma with myogenic differentiation: long-term survival in a patient treated with aggressive combination therapy and autologous stem cell transplantation.

Authors:  William Rattenberry; Colleen H McDonough; Peter C Burger; Kenneth J Cohen
Journal:  J Neurooncol       Date:  2011-06-19       Impact factor: 4.130

6.  OTX2 represses myogenic and neuronal differentiation in medulloblastoma cells.

Authors:  Ren-Yuan Bai; Verena Staedtke; Hart G Lidov; Charles G Eberhart; Gregory J Riggins
Journal:  Cancer Res       Date:  2012-09-17       Impact factor: 12.701

Review 7.  Imaging of the unusual pediatric 'blastomas'.

Authors:  Georgia Papaioannou; Neil J Sebire; Kieran McHugh
Journal:  Cancer Imaging       Date:  2009-02-02       Impact factor: 3.909

Review 8.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

9.  The role of immunohistochemistry in medullomyoblastoma--a case series highlighting divergent differentiation.

Authors:  Man Updesh S Sachdeva; Mahesha Vankalakunti; Aruna Rangan; Bishan D Radotra; Rajesh Chhabra; Rakesh K Vasishta
Journal:  Diagn Pathol       Date:  2008-04-25       Impact factor: 2.644

10.  Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi Anemia.

Authors:  Jingying Xu; Ashley Sloane Margol; Anju Shukla; Xiuhai Ren; Jonathan L Finlay; Mark D Krieger; Floyd H Gilles; Fergus J Couch; Meraj Aziz; Eric T Fung; Shahab Asgharzadeh; Michael T Barrett; Anat Erdreich-Epstein
Journal:  Front Oncol       Date:  2015-08-27       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.